191 related articles for article (PubMed ID: 425756)
1. [Immune complexes in multiple sclerosis and experimental allergic encephalomyelitis].
Vilkov GA; Martirosian VV; Mezhova LI; Mzokova VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):139-42. PubMed ID: 425756
[TBL] [Abstract][Full Text] [Related]
2. [Role of neuroallergy in the pathogenesis of multiple sclerosis].
Vilkov GA; Martirosian VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):206-9. PubMed ID: 3885657
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
Lublin FD
Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):182-7. PubMed ID: 1377972
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic Resonance Imaging study of the role of the blood-brain barrier in the pathogenesis of experimental allergic encephalomyelitis: application to multiple sclerosis].
Chambron J; Namer IJ; Steibel J; Gounot D; Armspach JP
Bull Acad Natl Med; 1994 Dec; 178(9):1647-63; discussion 1663-5. PubMed ID: 7788436
[TBL] [Abstract][Full Text] [Related]
5. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
Stuerzebecher S; Martin R
Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
[TBL] [Abstract][Full Text] [Related]
6. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
[TBL] [Abstract][Full Text] [Related]
7. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
Paterson PY; Day ED
Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
[No Abstract] [Full Text] [Related]
8. [Polymorphonuclear rosettes in the peripheral blood of multiple sclerosis patients].
Matveeva TV; Kamzeev VD; Shaĭdullina FS; Riazantseva IN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):133-6. PubMed ID: 106611
[TBL] [Abstract][Full Text] [Related]
9. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
Seil FJ; Agrawal HC
Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
[No Abstract] [Full Text] [Related]
10. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F; Shin ML
J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199
[TBL] [Abstract][Full Text] [Related]
11. [Multiple sclerosis and the immune system. Progress and unsolved problems].
Mertin J
Med Klin; 1978 Dec; 73(50):1752-67. PubMed ID: 82904
[No Abstract] [Full Text] [Related]
12. [Several components of the kinin system in multiple sclerosis and experimental allergic encephalomyelitis].
Martirosian VV; Vilkov GA; Miliutin LV; Mitiureva FI; Khoruzhaia TA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1165-8. PubMed ID: 4420143
[No Abstract] [Full Text] [Related]
13. [Experimental allergic encephalomyelitis as a model for the study of therapeutic concepts for encephalomyelitis disseminata].
Meyer-Rienecker HJ; Günther J; Gundlach HJ; Schröter P; Hitzchke B
Psychiatr Neurol Med Psychol (Leipz); 1975 Dec; 27(12):725-36. PubMed ID: 59933
[TBL] [Abstract][Full Text] [Related]
14. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
Béraud-Juven E
Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
[TBL] [Abstract][Full Text] [Related]
15. [Role of immune complexes in the pathogenesis of experimental polyneuritis and encephalomyelitis].
Pleskov VM; Zhitnukhin IuA; Konovalov GV; Denisenko AD
Vopr Med Khim; 1982; 28(2):81-8. PubMed ID: 6177101
[No Abstract] [Full Text] [Related]
16. [Aspects of the value of humoral antibodies in encephalomyelitis of neuroallergic origin].
Hitzschke B; Günther J; Meyer-Rienecker HJ
Psychiatr Neurol Med Psychol (Leipz); 1975 Jan; 27(1):1-15. PubMed ID: 178016
[TBL] [Abstract][Full Text] [Related]
17. Immunological studies in experimental allergic encephalomyelitis and in multiple sclerosis with special reference to pathogenesis and diagnosis.
Lamoureux G
Proc Aust Assoc Neurol; 1966; 4():125-32. PubMed ID: 4165114
[No Abstract] [Full Text] [Related]
18. Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.
Dimitrijević M; Rauski A; Radojević K; Kosec D; Stanojević S; Pilipović I; Leposavić G
Eur J Pharmacol; 2007 Dec; 577(1-3):170-82. PubMed ID: 17854797
[TBL] [Abstract][Full Text] [Related]
19. Anti-neuroglial and anti-neuronal cell factors in experimental allergic encephalomyelitis and multiple sclerosis.
Bornstein MB
Int Arch Allergy Appl Immunol; 1969; 36():Suppl:574-607. PubMed ID: 4906733
[No Abstract] [Full Text] [Related]
20. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
Kálmán B; Lublin FD
Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
